How Cole’s Logan Beckstrom battled leukemia and learned basketball along the way
While Logan Beckstrom is not battling leukemia anymore, he still has the same fight and level of determination and grit on the basketball court.
PharmaTimes3d
Amlenetug receives FDA Fast Track Designation
Amlenetug received Orphan Drug Designation (ODD) from the US FDA in April 2024, the EMA in May 2021 and SAKIGAKE designation ...
Pharmabiz9h
AskBio announces first participant randomized in Europe in GenePHIT phase 2 trial of AB-1002 to treat congestive heart failure
Research Triangle Park, North Carolina Saturday, February 15, 2025, 17:00 Hrs [IST] ...
Pharmabiz1d
Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy
Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy: Basel Friday, February 14, 2025, 13:00 Hrs [IST] Roche, announced that the US Food ...
First Participant Randomized in AskBio European Phase 2 Gene Therapy Trial for Congestive Heart Failure
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...
Le Lézard3d
Social Media Got You Stressed? This Private Community Puts Mental Health First
Lisane Basquiat is launching the Shaping Freedom Wellness Community on February 17. This free digital sanctuary is designed to counter the anxiety, stress, and disconnection fueled by social media.
Le Lézard3d
Pizza Nova celebrates unveiling of the Sam & Gemma Primucci and Family Computed Tomography Unit at Scarborough Health Network
Pizza Nova and the Primucci family celebrate the unveiling of The Sam & Gemma Primucci and Family Computed Tomography Unit at the new Northpine Diagnostic Imaging Department at Scarborough Health ...
Biohaven Announces FDA Acceptance And Priority Review Of Troriluzole New Drug Application For The Treatment Of Spinocerebellar Ataxia
Melissa Beiner, M.D., SCA Clinical Development Lead at Biohaven, commented, Our NDA filing is the culmination of over 8 years of clinical research a ...
Asklepios BioPharmaceutical, Inc. (AskBio): First Participant Randomized in AskBio European Phase 2 Gene Therapy Trial for Congestive Heart Failure
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) ...
Medindia3d
Novartis receives Health Canada approval for Fabhalta® oral treatment for adult patients with PNH
Canada NewsWire MONTREAL, Feb. 13, 2025 MONTREAL, Feb. 13, 2025 /CNW/ - Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance for Fabhalta® ...